ZFP36 and breast cancer: Besides, analysis of this dataset also revealed that, in spite of clear TTP/ZFP36 expression downregulation in mammary tumors, high expression of this gene was not associated with better prognosis, considering all breast cancer subtypes, and that overall survival (OS) time was even shorter if only patients with basal-like subtype were considered (Figure 2F).